On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Dutch Bros Inc. BROS.
On May 7, Dutch Bros posted better-than-expected first-quarter financial results and raised its full-year revenue guidance.
“The outlook is fabulous. There is a lawsuit in July that, involving formula,” Cramer said when asked about Abbott Laboratories ABT. “We're waiting until at least it gets to par or 100 to be able to buy more. But we believe in the company.”
On April 17, Abbott Laboratories reported better-than-expected earnings for its first quarter. The company posted first-quarter sales of $9.96 billion, up 10.8% on an organic basis for the underlying base business, beating the consensus of $9.88 billion. Abbott's adjusted diluted earnings per share was 98 cents, beating the analyst estimates of 95 cents.
Cramer commented on Canada Goose Holdings Inc. GOOS: “When I see a company report that kind of number that good and it doesn't go up, I say, ain't nothing going to get this thing going.”
On May 16, Canada Goose Hold reported better-than-expected fourth-quarter FY24 earnings. The company reported fourth-quarter sales growth of 22% year-on-year to C$358 million, beating the analyst consensus estimate of C$315.491 million.
The “Mad Money” host said Nutanix, Inc. NTNX is “what the market wants right now. It's enterprise software, enterprise cloud platforms. People can't get enough of it.”
The San Jose, California-based company is expected to report its financial results for the third quarter of fiscal year 2024, after the closing bell on Wednesday, May 29.
MeiraGTx Holdings plc MGTX is a “worthy spec,” Cramer said, “You want to be there because it's limited downside and some nice upside.”
On May 9, MeiraGTx posted a narrower-than-expected loss for its first quarter.
Price Action:
- Abbott Laboratories shares fell 0.9% to settle at $103.21 on Monday.
- Nutanix shares gained 2.7% to close at $72.16
- Dutch Bros shares gained 0.2% to settle at $36.77 on Monday.
- Canada Goose shares fell 1.3% to settle at $13.12.
- MeiraGTx shares fell 3% to close at $5.54 on Monday.
Read Next: $3.5M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Image: Shutterstock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
